Welltower (NYSE:WELL) Price Target Raised to $142.00

Welltower (NYSE:WELL) had its price objective upped by equities research analysts at Scotiabank from $133.00 to $142.00 in a report issued on Monday,Benzinga reports. The firm presently has a “sector outperform” rating on the real estate investment trust’s stock. Scotiabank’s price target would indicate a potential upside of 2.19% from the company’s previous close.

A number of other brokerages have also recently commented on WELL. Royal Bank of Canada increased their target price on shares of Welltower from $101.00 to $114.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th. Wolfe Research upgraded shares of Welltower to a “strong-buy” rating in a research report on Friday, August 9th. Evercore ISI lifted their price target on shares of Welltower from $106.00 to $114.00 and gave the company an “in-line” rating in a research report on Monday, September 16th. StockNews.com upgraded shares of Welltower from a “sell” rating to a “hold” rating in a research report on Wednesday, October 30th. Finally, Wedbush raised their price objective on shares of Welltower from $100.00 to $120.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Five equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Welltower has a consensus rating of “Moderate Buy” and a consensus price target of $117.50.

Welltower Stock Performance

Shares of NYSE WELL opened at $138.96 on Monday. The company’s fifty day moving average price is $131.47 and its 200 day moving average price is $117.65. Welltower has a 1 year low of $85.40 and a 1 year high of $140.19. The company has a market capitalization of $86.53 billion, a PE ratio of 91.42, a price-to-earnings-growth ratio of 3.09 and a beta of 1.20. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

Welltower (NYSE:WELL) last posted its quarterly earnings data on Monday, October 28th. The real estate investment trust reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.31). The company had revenue of $2.06 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Welltower had a net margin of 12.22% and a return on equity of 3.20%. The business’s revenue for the quarter was up 23.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.92 earnings per share. On average, research analysts predict that Welltower will post 4.3 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. First Foundation Advisors acquired a new position in shares of Welltower in the 2nd quarter valued at $26,000. TruNorth Capital Management LLC purchased a new stake in shares of Welltower during the 2nd quarter worth $27,000. Meeder Asset Management Inc. purchased a new stake in shares of Welltower during the 2nd quarter worth $30,000. Centerpoint Advisors LLC purchased a new stake in shares of Welltower during the 2nd quarter worth $31,000. Finally, Fortitude Family Office LLC boosted its position in shares of Welltower by 37.0% during the 3rd quarter. Fortitude Family Office LLC now owns 289 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 78 shares in the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Welltower Company Profile

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.